Sapreme Technologies

Sapreme Technologies

Foundation date

3 aug 2016

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Drug delivery
• #Therapeutics - Proteins
• #Therapeutics - Small molecules
• #Medtech - Regenerative Medicine
• #Supplier - Electronics

Therapeutic areas

• #Musculoskeletal system and connective tissue
• #Neoplasms / cancer / oncology

Biotechnical research and development on medical products and pharmaceutical processes and of food.

Full description:

Sapreme's mission is to develop improved macromolecular therapeutics such as antibody targeted antisense oligonucleotides (ASOs) for the treatment of cancer and other indications. Sapreme’s innovative endosomal escape platform is designed to allow therapeutics to reach their target without becoming entrapped by the endosome. Endosomal entrapment poses a significant hurdle for the drug discovery and development industry, currently limiting the development of a broad range of potential macromolecular therapeutics to ‘undruggable’ intracellular targets. An effective solution to endosomal entrapment could be of immense value to the therapeutic landscape, as it enables the development of truly differentiated therapeutics to such novel targets.